About 2-[4-[[4-[[4-[6-[methyl-[3-(methylamino)propyl]amino]-3-pyridinyl]pyrimidin-2-yl]amino]-2-pyridinyl]methyl]piperazin-1-yl]acetic acid
2-[4-[[4-[[4-[6-[methyl-[3-(methylamino)propyl]amino]-3-pyridinyl]pyrimidin-2-yl]amino]-2-pyridinyl]methyl]piperazin-1-yl]acetic acid (PubChem CID 118428065) has the molecular formula C26H35N9O2
and a molecular weight of 505.63 g/mol. Its IUPAC name is 2-[4-[[4-[[4-[6-[methyl-[3-(methylamino)propyl]amino]-3-pyridinyl]pyrimidin-2-yl]amino]-2-pyridinyl]methyl]piperazin-1-yl]acetic acid.
Molecular Properties
| Compound Name | 2-[4-[[4-[[4-[6-[methyl-[3-(methylamino)propyl]amino]-3-pyridinyl]pyrimidin-2-yl]amino]-2-pyridinyl]methyl]piperazin-1-yl]acetic acid |
| PubChem CID | 118428065 |
| Molecular Formula | C26H35N9O2 |
| Molecular Weight | 505.63 g/mol |
| Exact Mass | 505.29 |
| IUPAC Name | 2-[4-[[4-[[4-[6-[methyl-[3-(methylamino)propyl]amino]-3-pyridinyl]pyrimidin-2-yl]amino]-2-pyridinyl]methyl]piperazin-1-yl]acetic acid |
| SMILES | CNCCCN(C)c1ccc(-c2ccnc(Nc3ccnc(CN4CCN(CC(=O)O)CC4)c3)n2)cn1 |
| InChI | InChI=1S/C26H35N9O2/c1-27-8-3-11-33(2)24-5-4-20(17-30-24)23-7-10-29-26(32-23)31-21-6-9-28-22(16-21)18-34-12-14-35(15-13-34)19-25(36)37/h4-7,9-10,16-17,27H,3,8,11-15,18-19H2,1-2H3,(H,36,37)(H,28,29,31,32) |
| InChIKey | PJOXYZLWONGJCY-UHFFFAOYSA-N |
| XLogP | 1.93 |
| TPSA | 122.64 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 505.63 |
| LogP ≤ 5 | 1.93 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Analyze 2-[4-[[4-[[4-[6-[methyl-[3-(methylamino)propyl]amino]-3-pyridinyl]pyrimidin-2-yl]amino]-2-pyridinyl]methyl]piperazin-1-yl]acetic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[4-[[4-[[4-[6-[methyl-[3-(methylamino)propyl]amino]-3-pyridinyl]pyrimidin-2-yl]amino]-2-pyridinyl]methyl]piperazin-1-yl]acetic acid?
The IUPAC name of 2-[4-[[4-[[4-[6-[methyl-[3-(methylamino)propyl]amino]-3-pyridinyl]pyrimidin-2-yl]amino]-2-pyridinyl]methyl]piperazin-1-yl]acetic acid (CID 118428065) is 2-[4-[[4-[[4-[6-[methyl-[3-(methylamino)propyl]amino]-3-pyridinyl]pyrimidin-2-yl]amino]-2-pyridinyl]methyl]piperazin-1-yl]acetic acid.
What is the SMILES notation for 2-[4-[[4-[[4-[6-[methyl-[3-(methylamino)propyl]amino]-3-pyridinyl]pyrimidin-2-yl]amino]-2-pyridinyl]methyl]piperazin-1-yl]acetic acid?
The canonical SMILES for 2-[4-[[4-[[4-[6-[methyl-[3-(methylamino)propyl]amino]-3-pyridinyl]pyrimidin-2-yl]amino]-2-pyridinyl]methyl]piperazin-1-yl]acetic acid is CNCCCN(C)c1ccc(-c2ccnc(Nc3ccnc(CN4CCN(CC(=O)O)CC4)c3)n2)cn1.
What is the InChIKey of 2-[4-[[4-[[4-[6-[methyl-[3-(methylamino)propyl]amino]-3-pyridinyl]pyrimidin-2-yl]amino]-2-pyridinyl]methyl]piperazin-1-yl]acetic acid?
The InChIKey is PJOXYZLWONGJCY-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H35N9O2/c1-27-8-3-11-33(2)24-5-4-20(17-30-24)23-7-10-29-26(32-23)31-21-6-9-28-22(16-21)18-34-12-14-35(15-13-34)19-25(36)37/h4-7,9-10,16-17,27H,3,8,11-15,18-19H2,1-2H3,(H,36,37)(H,28,29,31,32).
What are the key properties of 2-[4-[[4-[[4-[6-[methyl-[3-(methylamino)propyl]amino]-3-pyridinyl]pyrimidin-2-yl]amino]-2-pyridinyl]methyl]piperazin-1-yl]acetic acid?
2-[4-[[4-[[4-[6-[methyl-[3-(methylamino)propyl]amino]-3-pyridinyl]pyrimidin-2-yl]amino]-2-pyridinyl]methyl]piperazin-1-yl]acetic acid has a molecular weight of 505.63 g/mol, XLogP of 1.93, 12 rotatable bonds, 3 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[[4-[[4-[6-[methyl-[3-(methylamino)propyl]amino]-3-pyridinyl]pyrimidin-2-yl]amino]-2-pyridinyl]methyl]piperazin-1-yl]acetic acid is sourced from PubChem (CID 118428065), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).